Medicare Part B, Breakthrough Drugs Get Reimbursement Boost In Senate COVID-19 Bill
Executive Summary
Legislation allows sponsors to request HCPCS code even before US FDA approval, but would extend the sequester until 2030 to pay for the temporary increase in payments for Part B drugs.